IBEX Limited - Common Share (IBEX)
Technology › Services-Computer Processing & Data Preparation
Price History
Feb 9, 2026 — May 9, 2026Investment Snapshot
- Trading 4% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 29.9% — good return on equity
- Revenue growing at 10% annually
IBEX Limited - Common Share (IBEX) is a Technology company operating in Services-Computer Processing & Data Preparation, listed on the NASDAQ , with a market capitalisation of $433 million . Key value metrics: P/E ratio 9.0, P/B ratio 2.69, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
IBEX Limited - Common Share — Fundamental Analysis Summary
IBEX Limited - Common Share (IBEX) is currently trading 4% above its Graham Number of $31.14, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a low trailing P/E ratio of 9.0x.
On financial health, IBEX shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 29.9% (sector average: -2.4%), and minimal leverage with a debt-to-equity ratio of 0.01.
StockPik's composite Value Score for IBEX is 100/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
IBEX shows revenue growing at 10% year-over-year, with earnings growing at 10%.